We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Information for patients, public and health care professionals.
Find out how to kill trees on site using chemical treatments to prevent the spread of pests and diseases.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
A form of IP that extends the protection of patented active ingredients present in pharmaceutical or plant protection products.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Patient group direction (PGD) templates for post exposure prophylaxis and treatment of flu for adult residents and staff of care homes.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Information for companies on the import and export of controlled drugs to and from the UK.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Guidance for industry on flexible approaches we are taking on good distribution practices.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).